13G Filing: Rima Senvest Management and Medigus Ltd. (MDGS)

Page 4 of 7 – SEC Filing

Item 1(a). Name of Issuer.
Medigus Ltd. (the “Issuer“)
Item 1(b). Address of Issuer’s Principal Executive Offices.

Omer Industrial Park, No. 7A

P.O. Box 3030

Omer 8496500

Israel

Item 2(a). Name of Person Filing.

This statement is filed by Senvest Management,
LLC and Richard Mashaal.

The reported securities are held in the accounts of Senvest Master
Fund, LP, Senvest Israel Partners Master Fund, LP and Senvest Global (KY), LP (collectively, the “Investment Vehicles“).

Senvest Management, LLC may be deemed to beneficially
own the securities held by the Investment Vehicles by virtue of Senvest Management, LLC’s position as investment manager of each
of the Investment Vehicles. Mr. Mashaal may be deemed to beneficially own the securities held by the Investment Vehicles by virtue
of Mr. Mashaal’s status as the managing member of Senvest Management, LLC. None of the foregoing should be construed in and of
itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.

Item 2(b). Address of Principal Business Office.

Senvest Management, LLC

540 Madison Avenue, 32nd Floor

New York, New York 10022

Richard Mashaal

c/o Senvest Management, LLC

540 Madison Avenue, 32nd Floor

New York, New York 10022

Item 2(c). Place of Organization.

Senvest Management, LLC – Delaware

Richard Mashaal – Canada

Item 2(d). Title of Class of Securities.
Ordinary Shares, par value NIS 0.10 per share
Item 2(e). CUSIP Number.
58471G201

Follow Medigus Ltd. (NASDAQ:MDGS)